04:38 AM EST, 02/05/2025 (MT Newswires) -- Novo Nordisk ( NVO ) reported Wednesday Q4 earnings of 6.34 Danish kroner ($0.88) per diluted share, up from 4.91 kroner a year earlier.

Analysts polled by FactSet expected 5.96 kroner.

Sales for the quarter ended Dec. 31 were 85.68 billion kroner, up from 65.86 billion kroner a year earlier.

Analysts polled by FactSet expected 80.7 billion kroner.

For 2025, the company expects sales growth at constant exchange rates of 16% to 24%.